GLP Weekly: Using young blood to battle Alzheimer’s ‘an exciting new start in a frustrating field’; NYT's Lipton defends anti-biotech group; and more!

GLP Features Articles by GLP staff and contributors

Accused of questionable science reporting on GMOs, New York Times’ Eric Lipton defends anti-biotech, anti-vax Moms Across America, group that harasses scientists Stephan Neidenbach Using young blood to battle Alzheimer’s could be ‘an exciting new start in a frustrating field’ Ricki Lewis Plans to introduce GMO crops in disarray, legislators angry after Uganda’s president rejects GMO cultivation law for second time Lominda Afedraru Regenerative Japanese stem cell treatment raises hopes for spinal cord injuries—but sparks ethical debate Amos Zeeberg Viewpoint: We need intensive agriculture to combat climate change and feed 10 billion people Ted Nordhaus Sensory overload: Some people genetically wired to detest bright lights, big sounds Kristen Hovet Viewpoint: Consumer genetic testing plagued by inaccuracies that can be misleading, or even harmful Emma Kowal, Jacqueline Savard, Jeffrey Craig Podcast: Food snobbery vs the Impossible Burger: A skeptical look at health claims about plant-based meat Alex Trembath, Cameron English How animal memories can be harnessed in the quest to treat Alzheimer’s April Reese No ‘gay gene’: Massive study finds no specific genetic predictors for sexual behavior, preferences Ricki Lewis